Evaluation of patients diagnosed with phenylketonuria and biotinidase deficiency by the newborn screening program: a ten-year retrospective study

dc.contributor.authorToktaş, İzzettin
dc.contributor.authorSarıbaş, Seyfettin
dc.contributor.authorCanpolat, Semih
dc.contributor.authorErdem, Özgür
dc.contributor.authorÖzbek, Mehmet Nuri
dc.date.accessioned2023-01-18T11:47:47Z
dc.date.available2023-01-18T11:47:47Z
dc.date.issued2022en_US
dc.departmentMAÜ, Fakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Halk Sağlığı Ana Bilim Dalıen_US
dc.description.abstractBackground. Phenylketonuria (PKU) and biotinidase deficiency (BD) are autosomal recessive diseases. If they are not identified and treated early, severe intellectual disability and developmental delay occur. This study was conducted to calculate the ten-year incidence of PKU and BD in the Diyarbakır province of Turkey. Methods. This cross-sectional study included patients born between 2011-2020 and diagnosed with PKU and BD. Patients with a clear diagnosis had their records evaluated retrospectively. Results. Between 2011 and 2020, blood was taken from 417,525 newborns’ heels in Diyarbakir province. As a result of further diagnostic testing, 53 PKU (Incidence: 1:7878) and 177 BD (Incidence: 1:2359) were detected. Of the patients with BD, 56% had profound BD and 44% had partial BD. The records of a total of 269 patients (PKU: 25; BD: 123; Hyperphenylalaninemia: 121) were examined. Parents of 65% (n=15) of the patients diagnosed with PKU and 46.6% (n=55) of the patients diagnosed with BD were consanguineous. Conclusions. The incidence of both PKU and BD was found to be high in our region. The high number of consanguineous marriages was regarded as the most important explanation for the high frequency of these illnesses.en_US
dc.identifier.citationToktaş, İ., Sarıbaş, S., Canpolat, S., Erdem, Ö., & Özbek, M. N. (2022). Evaluation of patients diagnosed with phenylketonuria and biotinidase deficiency by the newborn screening program: a ten-year retrospective study. The Turkish Journal of Pediatrics, 64(6), 985-992.en_US
dc.identifier.doi10.24953/turkjped.2022.467en_US
dc.identifier.endpage992en_US
dc.identifier.issue6en_US
dc.identifier.pmid36583880en_US
dc.identifier.scopus2-s2.0-85145424811en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage985en_US
dc.identifier.trdizinid1149143en_US
dc.identifier.urihttps://doi.org/10.24953/turkjped.2022.467
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/36583880/
dc.identifier.urihttps://hdl.handle.net/20.500.12514/3343
dc.identifier.volume64en_US
dc.identifier.wosWOS:001079904600002en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherThe Turkish Journal of Pediatricsen_US
dc.relation.ispartofThe Turkish Journal of Pediatricsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectbiotinidase deficiency, incidence, newborn screening, phenylketonuria.en_US
dc.titleEvaluation of patients diagnosed with phenylketonuria and biotinidase deficiency by the newborn screening program: a ten-year retrospective studyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
pdf_TJP_2512.pdf
Boyut:
504.97 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Full Text - Article
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: